In this second of two parts on the developing participant diversity movement, sponsor, CRO and site representatives discuss the impact ...

This article reviews the proceedings of a multi-stakeholder conference about the current state of diversity in clinical trials and outlines

If the clinical trial industry is serious about promoting diversity, it's time to take a holistic approach to patient outreach and eschew it